Ecto-5′-nucleotidase (CD73) is central to the generation of extracellular adenosine. Previous studies have highlighted a detrimental role for extracellular adenosine in cancer, as it dampens T cell–mediated immune responses. Here, we determined that, in contrast to other cancers, CD73 is markedly downregulated in poorly differentiated and advanced-stage endometrial carcinoma compared with levels in normal endometrium and low-grade tumors. In murine models, CD73 deficiency led to a loss of endometrial epithelial barrier function, and pharmacological CD73 inhibition increased in vitro migration and invasion of endometrial carcinoma cells. Given that CD73-generated adenosine is central to regulating tissue protection and physiology in normal tissues, we hypothesized that CD73-generated adenosine in endometrial carcinoma induces an innate reflex to protect epithelial integrity. CD73 associated with cell-cell contacts, filopodia, and membrane zippers, indicative of involvement in cell-cell adhesion and actin polymerization–dependent processes. We determined that CD73-generated adenosine induces cortical actin polymerization via adenosine A1 receptor (A1R) induction of a Rho GTPase CDC42–dependent conformational change of the actin-related proteins 2 and 3 (ARP2/3) actin polymerization complex member N-WASP. Cortical F-actin elevation increased membrane E-cadherin, β-catenin, and Na+K+ ATPase. Together, these findings reveal that CD73-generated adenosine promotes epithelial integrity and suggest why loss of CD73 in endometrial cancer allows for tumor progression. Moreover, our data indicate that the role of CD73 in cancer is more complex than previously described.
Jessica L. Bowser, Michael R. Blackburn, Gregory L. Shipley, Jose G. Molina, Kenneth Dunner Jr., Russell R. Broaddus
Title and authors | Publication | Year |
---|---|---|
Targeting CD73 to augment cancer immunotherapy
M Roh, DA Wainwright, JD Wu, Y Wan, B Zhang |
Current Opinion in Pharmacology | 2020 |
Varied functions of immune checkpoints during cancer metastasis
A Safarzadeh, M Alizadeh, F Beyranvand, RF Jozaaee, K Hajiasgharzadeh, A Baghbanzadeh, A Derakhshani, A Argentiero, B Baradaran, N Silvestris |
Cancer Immunology, Immunotherapy | 2020 |
CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
JB Harvey, LH Phan, OE Villarreal, JL Bowser |
Frontiers in immunology | 2020 |
The adenosine pathway in immuno-oncology
B Allard, D Allard, L Buisseret, J Stagg |
Nature Reviews Clinical Oncology | 2020 |
The yin and yang functions of extracellular ATP and adenosine in tumor immunity
L Feng, Y Cai, M Zhu, L Xing, X Wang |
Cancer Cell International | 2020 |
CD73: A Promising Biomarker in Cancer Patients
R Turiello, A Pinto, S Morello |
Frontiers in pharmacology | 2020 |